COPENHAGEN (Reuters) – Novo Nordisk’s widely used diabetes drug Ozempic delayed progression of chronic kidney disease in diabetes patients, a large late-stage study found, cutting the […]

TOPLINE: Metformin cuts the risk for diabetic nephropathy (DN) and major kidney and cardiovascular events in patients with newly diagnosed type 2 diabetes (T2D) across various […]

TOPLINE: A narrower focus on weight loss by patients, health professionals, and clinical practice guidelines may hinder dieticians from implementing nonweight-focused approaches (NWFAs) to support healthy […]

TOPLINE: People with diabetes who live in small towns in the United States experience higher rates of complications than those living in cities and remote areas. […]

TOPLINE: More than a billion children, adolescents, and adults are living with obesity, globally, with rates of obesity among children and adolescents quadrupling between 1990 and […]

TOPLINE: The risk of developing gynecologic cancer is lower in women with hyperthyroidism than in those without it, found a large study.  METHODOLOGY: Thyroid disease and […]

TOPLINE: Hybrid closed-loop (HCL) systems may ease severe diabetes distress in some adults with type 1 diabetes (T1D), but not in adolescents. METHODOLOGY: Previous findings suggest […]

TOPLINE: Continued denosumab treatment is associated with a lower risk for diabetes in adults with osteoporosis older than 65 years, found a large-scale cohort study in […]